Allergic rhinitis indication may lead to diagnosis errors -- allergy cmte. member.
This article was originally published in The Tan Sheet
Executive Summary
NASALCROM BROAD RHINITIS OTC INDICATION PRESENTS "RISK" OF EXTENDED USE by consumers for whom the medication would be "ineffective," James Li, MD/PhD, Mayo Clinic, said Oct. 10 at a meeting of FDA's Nonprescription Drugs and Pulmonary-Allergy Drugs Advisory Committees in Bethesda, Md. held to discuss McNeil's proposed Rx-to-OTC switch of cromolyn sodium nasal spray. The anti-allergy nasal treatment was recommended for prevention and treatment of allergic rhinitis, covering both seasonal and perennial indications.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning